title: Protective effect of l-carnitine against acrylamide-induced DNA damage in somatic and germ cells of mice.
abstract: Recent findings of acrylamide (AA) in many common foods have sparked renewed interest in assessing human health hazards. AA was evaluated by the International Agency for Research on Cancer as probably carcinogenic to humans. For this reason, the aim of this study is to evaluate the potential genotoxic effect of AA using chromosomal aberration analysis and micronucleus (MN) test in mouse bone-marrow cells and morphological sperm abnormalities. The result of the present work indicated that treatment with a single dose of 10, 20, or 30 mg/kg b.wt. of AA for 24 h and the repeated dose of 10 mg/kg b.wt. for 1and 2 weeks induced a statistically significant increase in the percentage of chromosomal aberrations and micronuclei in bone- marrow cells. These percentages reduced significantly in all groups treated with AA and the protective agent l-carnitine. Also the results indicated that the dose 10, 20 and 30 mg/kg b.wt. of AA induced a statistically significant percentage of morphological sperm abnormalities compared with the control group. Such effect reached its maximum (7.24 ± 0.61) with the highest tested dose which reduced to (4.02 ± 0.58) in the group treated with the same dose of AA and l-carnitine. In conclusion, the results confirm the protective role of LC against the mutagenicity of AA.
authors: College of Science for Girls, EL-dammam University, Saudi Arabia.
authors: Hind Abdullah Seed
authors: HA
authors: Alzahrani
keywords: Acrylamide; Antimutagenicity; Chromosomal aberrations; Mice; Micronuclei; Sperm abnormalities; l-carnitine
references: Mutat Res. 1995 Aug;330(1-2):71-99
references: 7623872
references: Annu Rev Nutr. 1998;18:39-61
references: 9706218
references: Food Chem Toxicol. 2003 Nov;41(11):1581-6
references: 12963011
references: Exp Cell Res. 1993 Jan;204(1):54-60
references: 8416796
references: Mutagenesis. 1988 May;3(3):263-8
references: 3137422
references: Int J Androl. 1988 Oct;11(5):379-94
references: 3235207
references: Mutat Res. 2009 May 12;664(1-2):64-8
references: 19428382
references: Nature. 2002 Oct 3;419(6906):449-50
references: 12368845
references: Mutagenesis. 2006 Jan;21(1):21-7
references: 16306135
references: Pharmacol Ther. 1990;47(1):61-71
references: 2195557
references: Mutat Res. 1994 Sep 1;309(2):285-91
references: 7520986
references: Mutat Res. 1988 Sep-Oct;209(1-2):91-4
references: 3173405
references: Postgrad Med J. 1996 Jan;72(843):45-50
references: 8746285
references: Mutat Res. 2006 Feb 28;603(2):151-8
references: 16387526
references: Andrologia. 1977 Jul-Sep;9(3):255-64
references: 907211
references: Chem Res Toxicol. 1999 Nov;12(11):1110-6
references: 10563837
references: Agents Actions. 1973 Jun;3(2):77-85
references: 4125456
references: Mutat Res. 2003 Mar 3;535(2):215-22
references: 12581540
references: Mutat Res. 1996 Dec 20;371(3-4):175-83
references: 9008719
references: Toxicol Sci. 2002 Feb;65(2):177-83
references: 11812921
references: Mutat Res. 2003 Feb 5;535(1):15-24
references: 12547279
references: Mutat Res. 1978 Jul;57(3):313-24
references: 672931
references: Carcinogenesis. 1993 Oct;14(10):2131-6
references: 8222066
references: Mutagenesis. 1991 Mar;6(2):137-41
references: 2056915
references: Cell Biol Toxicol. 2000;16(2):99-104
references: 10917565
references: Chem Res Toxicol. 2003 Oct;16(10):1328-37
references: 14565774
references: Environ Mol Mutagen. 1989;13(3):218-26
references: 2707253
references: Mutat Res. 2008 May 31;653(1-2):50-6
references: 18485803
references: Mutat Res. 1970 May;9(5):527-49
references: 5424720
references: Chromosoma. 1965 Jun 28;16(6):658-67
references: 5862838
references: Graefes Arch Clin Exp Ophthalmol. 2007 Apr;245(4):588-94
references: 16915402
references: Mutat Res. 1988 Nov;206(3):379-85
references: 3200258
references: Arch Biochem Biophys. 2002 Sep 1;405(1):55-64
references: 12176057
references: Free Radic Biol Med. 1999 May;26(9-10):1158-65
references: 10381186
references: Mutat Res. 2005 Nov 10;587(1-2):16-25
references: 16168704
references: Cancer Res. 1985 Aug;45(8):3465-70
references: 4016731
references: Occup Environ Med. 2001 Sep;58(9):609
references: 11529235
references: Reprod Toxicol. 2010 Apr;29(2):225-30
references: 19903525
references: Mutat Res. 2008 Feb 29;650(2):165-74
references: 18201923
references: Pharmacol Res. 2002 Oct;46(4):363-70
references: 12361700
references: Mutat Res. 1986 Jan;173(1):35-40
references: 3941677
references: Chem Biol Interact. 2004 Oct 15;149(2-3):137-49
references: 15501435
references: Arch Histol Cytol. 2004 Nov;67(4):349-60
references: 15700542
references: Toxicol In Vitro. 2007 Dec;21(8):1486-92
references: 17692500
references: Acta Vet Hung. 2001;49(3):341-8
references: 11702346
references: Mutat Res. 1983 May;115(1):1-72
references: 6835246
references: Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2471-8
references: 18006939
references: J Nutr. 2003 May;133(5):1286-90
references: 12730411
references: Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2356-60
references: 10051646
references: Arch Biochem Biophys. 1992 Aug 1;296(2):394-401
references: 1321584
references: J Agric Food Chem. 2003 Jul 30;51(16):4504-26
references: 14705871
references: Br J Cancer. 2003 Jan 13;88(1):84-9
references: 12556964
references: Am J Physiol Cell Physiol. 2002 Sep;283(3):C802-10
references: 12176737
references: Brain Res. 2002 Aug 23;947(1):50-6
references: 12144852
references: J Occup Med. 1989 Jul;31(7):614-7
references: 2769457
references: Nutr Rev. 1997 Nov;55(11 Pt 1):383-9
references: 9420448
references: Carcinogenesis. 1995 May;16(5):1161-5
references: 7767980
references: Mutat Res. 2009 May 31;676(1-2):87-92
references: 19393333
references: Arch Toxicol. 2006 Dec;80(12):820-8
references: 16699760
references: Toxicol Lett. 2004 Mar 1;147(2):127-31
references: 14757316
references: Mutat Res. 2006 Feb 28;603(2):145-50
references: 16413820